Skip to main content

Perceptive Advisors LLC

SEC CIK
0001224962
Latest filing
Aug 14, 2026

ADMA holding history

Adma Biologics, Inc. in every 13F filed by Perceptive Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADMA overviewAll 13F holders of ADMAFull Q2 2026 holdings

Shares (Q2 2026)
113,765
Value
$952.2K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ADMA by Perceptive Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026113,765$952.2K<0.1%−353,468−75.7%ReducedHolders
Q1 2026467,233$4.21M0.1%−416,235−47.1%ReducedHolders
Q4 2025883,468$16.1M0.3%−270,000−23.4%ReducedHolders
Q3 20251,153,468$16.9M0.5%−150,000−11.5%ReducedHolders
Q2 20251,303,468$23.7M0.9%−69,765−5.1%ReducedHolders
Q1 20251,373,233$27.2M1.0%+482,953+54.2%AddedHolders
Q4 2024890,280$15.3M0.4%−169,920−16.0%ReducedHolders
Q3 20241,060,200$21.2M0.5%−1,710,800−61.7%ReducedHolders
Q2 20242,771,000$31.0M0.7%−3,662,369−56.9%ReducedHolders
Q1 20246,433,369$42.5M0.7%00.0%UnchangedHolders
Q4 20236,433,369$29.1M0.7%−550,950−7.9%ReducedHolders
Q3 20236,984,319$25.0M0.8%−4,915,936−41.3%ReducedHolders
Q2 202311,900,255$43.9M1.3%00.0%UnchangedHolders
Q1 202311,900,255$39.4M1.2%00.0%UnchangedHolders
Q4 202211,900,255$46.2M1.3%+966,868+8.8%AddedHolders
Q3 202210,933,387$26.6M0.8%−587,715−5.1%ReducedHolders
Q2 202211,521,102$22.8M0.7%−412,285−3.5%ReducedHolders
Q1 202211,933,387$21.8M0.5%00.0%UnchangedHolders
Q4 202111,933,387$16.8M0.3%−1,328,988−10.0%ReducedHolders
Q3 202113,262,375$15.0M0.2%−3,322,427−20.0%ReducedHolders
Q2 202116,584,802$26.5M0.3%00.0%UnchangedHolders
Q1 202116,584,802$29.2M0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.